Mitochondrial Dysfunction and Reactive Oxygen Species in Aging and Related Diseases

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular Genetics and Genetic Diseases".

Deadline for manuscript submissions: closed (31 August 2025) | Viewed by 1997

Special Issue Editors


E-Mail Website
Guest Editor
Donald W. Reynolds Department of Geriatrics and Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Interests: mitochondria; cardiac health; transgenesis; neuroinflammation; cell biology

E-Mail Website
Guest Editor
Donald W. Reynolds Department of Geriatrics and Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Interests: Alzheimer's disease; balance problems; chronic illness; dementia; memory problems; urinary incontinence

Special Issue Information

Dear Colleagues,

Mitochondrial dysfunction plays a significant role in the aging process and is associated with various age-related diseases. Understanding and addressing mitochondrial health are crucial for developing interventions that can improve quality of life and mitigate the effects of aging. Aging is characterized by a progressive decline in mitochondrial function, which is primarily caused by elevated levels of reactive oxygen species (ROS) and mitochondrial DNA mutations. These ROS induce oxidative damage to cellular components, leading to diminished respiratory chain activity and reduced ATP production. Mitochondrial fission and fusion are essential for regulating mitochondrial function, metabolism, and quality control. As we age, disruptions in these processes can hinder mitophagy. This impairment results in the build-up of defective mitochondria within cells, further escalating mitochondrial damage and impairing cellular function. Consequently, genetic mutations or declines in mitochondrial dynamics and quality control are linked to the development of various age-related disorders, including metabolic syndrome, neurodegenerative diseases, cardiovascular conditions, and cancer.

This Special Issue highlights the latest research on the role of mitochondrial dysfunction in aging and disease. We invite authors to submit original research and review articles that explore how mitochondrial abnormalities contribute to disease development and progression. We welcome submissions focused on cutting-edge mitochondrial-based therapies with potential for clinical translation, as well as approaches that address mitochondrial biogenesis, clearance, and signaling. We hope that our Special Issue will reflect current and novel insights into the role of mitochondria in aging and disease.

Dr. Pankaj Patyal
Dr. Gohar Azhar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondrial dysfunction
  • aging
  • reactive oxygen species
  • mitochondrial dynamics
  • mitophagy
  • mitochondrial biogenesis
  • age-related disorders

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 6008 KB  
Review
Mitochondrial Dynamics in Aging Heart
by Pankaj Patyal, Gohar Azhar, Ambika Verma, Shakshi Sharma, Jyotsna Shrivastava, Sayed Aliul Hasan Abdi, Xiaomin Zhang and Jeanne Y. Wei
Biomedicines 2025, 13(11), 2603; https://doi.org/10.3390/biomedicines13112603 - 24 Oct 2025
Viewed by 1518
Abstract
Aging is a major risk factor for cardiovascular disease, driving progressive structural and functional decline of the myocardium. Mitochondria, the primary source of ATP through oxidative phosphorylation, are essential for cardiac contractility, calcium homeostasis, and redox balance. In the aging heart, mitochondria show [...] Read more.
Aging is a major risk factor for cardiovascular disease, driving progressive structural and functional decline of the myocardium. Mitochondria, the primary source of ATP through oxidative phosphorylation, are essential for cardiac contractility, calcium homeostasis, and redox balance. In the aging heart, mitochondria show morphological alterations including cristae disorganization, swelling, and fragmentation, along with reduced OXPHOS efficiency. These defects increase proton leak, lower ATP production, and elevate reactive oxygen species (ROS), causing oxidative damage. Concurrent disruptions in mitochondrial fusion and fission further impair turnover and quality control, exacerbating mitochondrial dysfunction and cardiac decline. Serum response factor (SRF) signaling, a crucial regulator of cytoskeletal and metabolic gene expression, plays a key role in modulating mitochondrial function during cardiac aging. Dysregulation of SRF impairs mitochondrial adaptability, contributing to dysfunction. Additionally, reduced levels of nicotinamide adenine dinucleotide (NAD+) hinder sirtuin-dependent deacetylation, further compromising mitochondrial efficiency and stress resilience. These cumulative defects activate regulated cell death pathways, leading to cardiomyocyte loss, fibrosis, and impaired diastolic function. Mitochondrial dysfunction therefore serves as both a driver and amplifier of cardiac aging, accelerating the transition toward heart failure. This narrative review aims to provide a comprehensive overview of mitochondrial remodeling in the aging myocardium, examining the mechanistic links between mitochondrial dysfunction and myocardial injury. We also discuss emerging therapeutic strategies targeting mitochondrial bioenergetics and quality control as promising approaches to preserve cardiac function and extend cardiovascular health span in the aging population. Full article
Show Figures

Figure 1

Back to TopTop